TIFA Human Pre-designed siRNA Set A contains three designed siRNAs for TIFA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIFAB Human Pre-designed siRNA Set A contains three designed siRNAs for TIFAB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tiflucarbine (BAY-P 4495) is a tetrahydrothieno-7-carboline derivative. Tiflucarbine is a potent antidepressant agent that binds at central serotonin (5-HT) binding sites. Tiflucarbine is a nonselective 5-HT (5-HT1 and 5-HT2) agonist[1][2].

TIGAR Human Pre-designed siRNA Set A contains three designed siRNAs for TIGAR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tigecycline (Standard) is the analytical standard of Tigecycline. This product is intended for research and analytical applications. Tigecycline (GAR-936) is a broad-spectrum glycylcycline antibiotic. The mean inhibitory concentration (MIC) of Tigecycline for E. coli (MG1655 strain) is approximately 125 ng/mL[1]. MIC50 and MIC90 are 1 and 2 mg/L for Acinetobacter baumannii (A. baumannii), respectively[2].

TIGIT Human Pre-designed siRNA Set A contains three designed siRNAs for TIGIT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tigloside (Actinotetraose hexatiglate) is a symmetrical tetrasaccharide esterified with Tiglic acids (HY-W012999), which is detected as a secondary metabolite of an actinomycete strain Amycolatopsis[1].

Tigloyl-CoA (Tiglyl-coenzyme A) is an intermediate product of isoleucine metabolism. Tigloyl-CoA is an inhibitor of N-acetylglutamate synthetase[1].

Tilorone is an orally active antiviral agent and interferon inducer that also has potential antineoplastic, immunomodulatory, and metabolic modulating effects. Tilorone induces an abnormally delayed interferon response and primarily stimulates interferon production in lymphoid tissue. Thus, Tilorone exerts antiviral effects and can be used as a chemotherapeutic agent. Tilorone has the potential to inhibit type […]

Tilorone is an orally active antiviral agent and interferon inducer that also has potential antineoplastic, immunomodulatory, and metabolic modulating effects. Tilorone induces an abnormally delayed interferon response and primarily stimulates interferon production in lymphoid tissue. Thus, Tilorone exerts antiviral effects and can be used as a chemotherapeutic agent. Tilorone has the potential to inhibit type […]

Tilorone is an orally active antiviral agent and interferon inducer that also has potential antineoplastic, immunomodulatory, and metabolic modulating effects. Tilorone induces an abnormally delayed interferon response and primarily stimulates interferon production in lymphoid tissue. Thus, Tilorone exerts antiviral effects and can be used as a chemotherapeutic agent. Tilorone has the potential to inhibit type […]

Tilorone is an orally active antiviral agent and interferon inducer that also has potential antineoplastic, immunomodulatory, and metabolic modulating effects. Tilorone induces an abnormally delayed interferon response and primarily stimulates interferon production in lymphoid tissue. Thus, Tilorone exerts antiviral effects and can be used as a chemotherapeutic agent. Tilorone has the potential to inhibit type […]

TIM-098a is a selective AAK1 inhibitor with an IC50 of 0.24 µM. TIM-098a has no inhibitory activity against CaMKK isoforms. TIM-098a inhibits AAK1-regulated endocytosis by suppressing AAK1 kinase activity[1].

TIMD4 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMELESS Human Pre-designed siRNA Set A contains three designed siRNAs for TIMELESS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMM10 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMM10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMM13 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMM13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMM17A Human Pre-designed siRNA Set A contains three designed siRNAs for TIMM17A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMM22 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMM22 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMM23 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMM23 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMM44 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMM44 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMM50 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMM50 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMM8A Human Pre-designed siRNA Set A contains three designed siRNAs for TIMM8A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMM8B Human Pre-designed siRNA Set A contains three designed siRNAs for TIMM8B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMM9 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMM9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMMDC1 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMMDC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Timosaponin E2 is an antiinflammatory agent, and inhibits active oxygen production[1].

TIMP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMP2 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMP3 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIMP4 Human Pre-designed siRNA Set A contains three designed siRNAs for TIMP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TINAG Human Pre-designed siRNA Set A contains three designed siRNAs for TINAG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TINAGL1 Human Pre-designed siRNA Set A contains three designed siRNAs for TINAGL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TINCR Human Pre-designed siRNA Set A contains three designed siRNAs for TINCR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TINF2 Human Pre-designed siRNA Set A contains three designed siRNAs for TINF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tinidazole (Standard) is the analytical standard of Tinidazole. This product is intended for research and analytical applications. Tinidazole, an orally available antibacterial agent, is a 5-nitroimidazole with selective activity against anaerobic bacteria and protozoa[1].

Tiotropium (Bromide) (Standard) is the analytical standard of Tiotropium (Bromide). This product is intended for research and analytical applications. Tiotropium Bromide (BA679 BR) is a muscarinic acetylcholine receptor (mAChR) antagonist that blocks the binding of the acetylcholine ligand and subsequent opening of the ligand-gated ion channel.

TIPARP Human Pre-designed siRNA Set A contains three designed siRNAs for TIPARP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tiparp Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tiparp gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tiparp Rat Pre-designed siRNA Set A contains three designed siRNAs for Tiparp gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

TIPIN Human Pre-designed siRNA Set A contains three designed siRNAs for TIPIN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tipranavir-d7 is deuterated labeled Tipranavir (HY-15148). Tipranavir (PNU-140690) inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-protease inhibitor (PI)-resistant HIV-1 isolates with IC50s of 66-410 nM[1][2]. Tipranavir inhibits SARS-CoV-2 3CLpro activity[3].

Tiprenolol is a β-adrenoceptor blocker. Tiprenolol can abolish the ventricular arrhythmias produced by adrenaline in dogs respired with halothane[1].